Document detail
ID

doi:10.1007/s00595-024-02815-z...

Author
Chikatani, Kenichi Ishida, Hideyuki Mori, Yoshiko Nakajima, Takeshi Ueki, Arisa Akagi, Kiwamu Takao, Akinari Yamada, Masayoshi Taniguchi, Fumitaka Komori, Koji Sasaki, Kazuhito Sudo, Tomoya Miyakura, Yasuyuki Chino, Akiko Yamaguchi, Tatsuro Tanakaya, Kohji Tomita, Naohiro Ajioka, Yoichi
Langue
en
Editor

Springer

Category

Medicine & Public Health

Year

2024

listing date

3/20/2024

Keywords
lynch syndrome rectal cancer colorectal cancer metachronous colorectal cancer = 0 9% risk index study colon ls resection cancer metachronous crc
Metrics

Abstract

Purpose This study evaluated the risk of metachronous colorectal cancer (CRC) after resection of index (first) rectal cancer in patients with Lynch syndrome (LS).

Methods Clinicopathological data of patients with genetically proven LS were retrospectively analyzed in this multicenter Japanese study.

The cumulative incidence of metachronous CRC and the overall survival were compared between patients with index rectal cancer (rectal group) and those with index colon cancer (colon group).

Results The median age at index CRC surgery was lower in the rectal group than in the colon group (37 vs. 46 years old, P  = 0.01).

The cumulative 5-, 10-, and 20-year incidences of metachronous CRC were 3.5%, 13.9%, and 21.1%, respectively, in the rectal cancer group and 14.9%, 22.0%, and 57.9%, respectively, in the colon cancer group ( P  = 0.02).

The overall survival curves were not significantly different between two groups ( P  = 0.23).

Conclusion This is the first report from an East Asian country to report the risk of metachronous CRC after resection of index rectal cancer in patients with LS.

Despite this study having several limitations, we cannot recommend extended resection, such as total proctocolectomy, for index rectal cancer as a standard surgical treatment in patients with LS.

Chikatani, Kenichi,Ishida, Hideyuki,Mori, Yoshiko,Nakajima, Takeshi,Ueki, Arisa,Akagi, Kiwamu,Takao, Akinari,Yamada, Masayoshi,Taniguchi, Fumitaka,Komori, Koji,Sasaki, Kazuhito,Sudo, Tomoya,Miyakura, Yasuyuki,Chino, Akiko,Yamaguchi, Tatsuro,Tanakaya, Kohji,Tomita, Naohiro,Ajioka, Yoichi, 2024, Risk of metachronous colorectal cancer after surgical resection of index rectal cancer in Lynch syndrome: a multicenter retrospective study in Japan, Springer

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw